Home -> Law Blog Directory -> Intellectual Property Law Blogs -> IPKat
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: IPKatNodus meeting
By Johanna Gibson, David Pearce, Jeremy Phillips and Ilanah Simon.
Douglas gave an overview of the 'Bolar' exemptions relating to experimental use of patented products. Most of this went over the IPKat's head, but there appears to be one main lesson from this, which is that if you are considering relying on the exemption it's best to get some very heavy duty advice first unless you like living dangerously.
The highlight of the evening, however, was Tom Hinchliffe who talked about the recent case of Actavis v Merck (see the IPKat's commentary here). Much of this case was about whether the court of appeal could go against an earlier judgment of theirs (BMS v Baker Norton, to be exact), and in the end it decided it could, partly because the EPO case law in the area was 'settled' and happened to arrive at the opposite answer to what appeared to be the case in the UK. Unfortunately, at the very last minute a new referral to the EPO Enlarged Board appeared, which seemed to cast a fair degree of doubt over the very issues that were thought to be settled. This was all very interesting, and will certainly keep the lawyers busy for a little while longer, but the IPKat was shocked to find out that his faint suspicions at the time (see the comment here) were actually correct. It was his posting here that apparently prompted the last minute panic, which resulted in a postscript being added to the judgment, which allowed an unusually extended time for leave to appeal to the House of Lords until after the Enlarged Board had delivered their decision.
Full post as published by IPKat on September 19, 2008 (boomark / email).
US Auto
Meeting Notification Regarding $10 Million Class Action Settlement.










